基于生物标志物的早期癌症检测：是否可行？
Biomarker-based early cancer detection: is it achievable?
机构信息
Program in Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
出版信息
Sci Transl Med. 2011 Nov 16;3(109):109fs9. doi: 10.1126/scitranslmed.3003272.
Abstract
A new mathematical model evaluates the power of blood-based biomarkers for early cancer detection.
摘要
一种新的数学模型评估了基于血液的生物标志物在早期癌症检测中的效力。
相似文献
1
Biomarker-based early cancer detection: is it achievable?基于生物标志物的早期癌症检测：是否可行？
Sci Transl Med. 2011 Nov 16;3(109):109fs9. doi: 10.1126/scitranslmed.3003272.
2
Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations.数学模型确定基于血液生物标志物的早期癌症检测策略和局限性。
Sci Transl Med. 2011 Nov 16;3(109):109ra116. doi: 10.1126/scitranslmed.3003110.
3
A Model-Based Personalized Cancer Screening Strategy for Detecting Early-Stage Tumors Using Blood-Borne Biomarkers.一种基于模型的个性化癌症筛查策略，用于利用血液生物标志物检测早期肿瘤。
Cancer Res. 2017 May 15;77(10):2570-2584. doi: 10.1158/0008-5472.CAN-16-2904. Epub 2017 Mar 10.
4
Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.癌症临床生物标志物的发现和验证：代谢组学和蛋白质组学相结合的综述。
Proteomics. 2019 May;19(10):e1700448. doi: 10.1002/pmic.201700448. Epub 2018 Nov 26.
5
Gynaecological cancer: Biomarker potential of CA-125 enhanced.妇科癌症：CA-125的生物标志物潜力增强。
Nat Rev Clin Oncol. 2015 Aug;12(8):437. doi: 10.1038/nrclinonc.2015.95. Epub 2015 May 26.
6
Early detection of breast cancer: new biomarker tests on the horizon?早期乳腺癌检测：新的生物标志物检测方法即将问世？
Mol Diagn Ther. 2009 Dec 1;13(6):349-57. doi: 10.1007/BF03256340.
7
Platelet RNA as Pan-Tumor Biomarker for Cancer Detection.血小板 RNA 作为癌症检测的泛肿瘤生物标志物。
Cancer Res. 2020 Apr 1;80(7):1371-1373. doi: 10.1158/0008-5472.CAN-19-3684. Epub 2020 Feb 19.
8
Multiplexed cancer biomarker detection using chip-integrated silicon photonic sensor arrays.使用芯片集成硅光子传感器阵列进行多重癌症生物标志物检测。
Analyst. 2016 Sep 21;141(18):5358-5365. doi: 10.1039/c6an01076h. Epub 2016 Jul 12.
9
Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement.评估用于肺癌早期检测的分子生物标志物：生物标志物何时可用于临床？美国胸科学会官方政策声明。
Am J Respir Crit Care Med. 2017 Oct 1;196(7):e15-e29. doi: 10.1164/rccm.201708-1678ST.
10
Liquid biopsy for the detection of clinical biomarkers in early breast cancer: new insights and challenges.液体活检在早期乳腺癌临床生物标志物检测中的应用：新的见解与挑战。
Pharmacogenomics. 2020 Apr;21(5):359-367. doi: 10.2217/pgs-2019-0130. Epub 2020 Apr 14.
引用本文的文献
1
Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer.循环肿瘤DNA检测可改善上皮性卵巢癌的复发预测。
BMC Cancer. 2024 Dec 22;24(1):1565. doi: 10.1186/s12885-024-13222-5.
2
Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC.罕见恶性肿瘤中的生物标志物发现：隐性遗传性营养不良性大疱性表皮松解症相关皮肤鳞状细胞癌的miRNA特征开发
Cancers (Basel). 2023 Jun 22;15(13):3286. doi: 10.3390/cancers15133286.
3
To Assist Oncologists: An Efficient Machine Learning-Based Approach for Anti-Cancer Peptides Classification.辅助肿瘤学家：一种基于机器学习的高效抗癌肽分类方法。
Sensors (Basel). 2022 May 25;22(11):4005. doi: 10.3390/s22114005.
4
Biosensing based on field-effect transistors (FET): Recent progress and challenges.基于场效应晶体管（FET）的生物传感：最新进展与挑战。
Trends Analyt Chem. 2020 Dec;133:116067. doi: 10.1016/j.trac.2020.116067. Epub 2020 Oct 9.
5
Modeling EV Kinetics for Use in Early Cancer Detection.用于早期癌症检测的 EV 动力学建模。
Adv Biosyst. 2020 Dec;4(12):e1900305. doi: 10.1002/adbi.201900305. Epub 2020 May 12.
6
On the need for the development of a cancer early detection, diagnostic, prognosis, and treatment response system.论癌症早期检测、诊断、预后及治疗反应系统开发的必要性。
Future Sci OA. 2019 Nov 29;6(2):FSO439. doi: 10.2144/fsoa-2019-0028.
7
Label-Free Telomerase Activity Detection via Electrochemical Impedance Spectroscopy.通过电化学阻抗谱进行无标记端粒酶活性检测。
ACS Omega. 2019 Oct 1;4(16):16724-16732. doi: 10.1021/acsomega.9b00783. eCollection 2019 Oct 15.
8
CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite.基于固载碳量子点的金纳米复合材料用于 CA19-9 胰腺肿瘤标志物的荧光免疫传感检测。
Int J Mol Sci. 2018 Apr 11;19(4):1162. doi: 10.3390/ijms19041162.
9
A Model-Based Personalized Cancer Screening Strategy for Detecting Early-Stage Tumors Using Blood-Borne Biomarkers.一种基于模型的个性化癌症筛查策略，用于利用血液生物标志物检测早期肿瘤。
Cancer Res. 2017 May 15;77(10):2570-2584. doi: 10.1158/0008-5472.CAN-16-2904. Epub 2017 Mar 10.
10
Predicting disease progression from short biomarker series using expert advice algorithm.使用专家建议算法从简短生物标志物序列预测疾病进展。
Sci Rep. 2015 May 20;5:8953. doi: 10.1038/srep08953.
本文引用的文献
1
Re: Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.关于：前列腺癌筛查：美国预防服务工作组建议声明。
J Urol. 2012 Oct;188(4):1181. doi: 10.1016/j.juro.2012.06.129. Epub 2012 Aug 15.
2
Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations.数学模型确定基于血液生物标志物的早期癌症检测策略和局限性。
Sci Transl Med. 2011 Nov 16;3(109):109ra116. doi: 10.1126/scitranslmed.3003110.
3
Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.基于小鼠肿瘤模型的蛋白质组谱分析的血浆肺癌特征。
Cancer Cell. 2011 Sep 13;20(3):289-99. doi: 10.1016/j.ccr.2011.08.007.
4
Distant metastasis occurs late during the genetic evolution of pancreatic cancer.远处转移发生在胰腺癌遗传进化的晚期。
Nature. 2010 Oct 28;467(7319):1114-7. doi: 10.1038/nature09515.
5
Early detection of ovarian cancer.卵巢癌的早期检测。
Biomark Med. 2008 Jun;2(3):291-303. doi: 10.2217/17520363.2.3.291.
6
Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.评估选定卵巢癌生物标志物的领先时间：一项巢式病例对照研究。
J Natl Cancer Inst. 2010 Jan 6;102(1):26-38. doi: 10.1093/jnci/djp438. Epub 2009 Dec 30.
7
The preclinical natural history of serous ovarian cancer: defining the target for early detection.浆液性卵巢癌的临床前自然史：确定早期检测的目标
PLoS Med. 2009 Jul;6(7):e1000114. doi: 10.1371/journal.pmed.1000114. Epub 2009 Jul 28.
8
Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.通过小RNA cDNA文库的下一代测序确定的上皮性卵巢癌中的微小RNA文库
PLoS One. 2009;4(4):e5311. doi: 10.1371/journal.pone.0005311. Epub 2009 Apr 23.
9
Phases of biomarker development for early detection of cancer.用于癌症早期检测的生物标志物开发阶段。
J Natl Cancer Inst. 2001 Jul 18;93(14):1054-61. doi: 10.1093/jnci/93.14.1054.
Zotero 插件